2023
Children's Oncology Group's 2023 blueprint for research: Surgery
Gow K, Lautz T, Malek M, Cost N, Newman E, Dasgupta R, Christison‐Lagay E, Tiao G, Davidoff A, Committee T. Children's Oncology Group's 2023 blueprint for research: Surgery. Pediatric Blood & Cancer 2023, 71: e30766. PMID: 37950538, PMCID: PMC10872730, DOI: 10.1002/pbc.30766.Peer-Reviewed Original ResearchVulvovaginal Complaints as the First Manifestation of Crohn's Disease in Children: Case Report
Brioso X, Banks D, Christison-Lagay E, Phatak U, Vash-Margita A. Vulvovaginal Complaints as the First Manifestation of Crohn's Disease in Children: Case Report. Journal Of Pediatric And Adolescent Gynecology 2023, 36: 494-496. PMID: 37196754, DOI: 10.1016/j.jpag.2023.05.007.Peer-Reviewed Original ResearchConceptsCrohn's diseasePediatric gynecologistImprovement of symptomsGastrointestinal inflammatory conditionsChronic constipationPrompt diagnosisPediatric populationVulvar irritationPremenarchal femalesVulvar complaintsCase reportInflammatory conditionsFirst manifestationVulvovaginal complaintsClear diagnosisHigh indexDiseaseDiagnosisFirst signAnatomical changesGynecologistsComplaintsTreatmentChildrenPoor growth
2015
Temsirolimus therapy and small bowel perforation in a pediatric patient with Clostridium septicum bacteremia
Herrin M, Rubinstein J, Christison-Lagay E. Temsirolimus therapy and small bowel perforation in a pediatric patient with Clostridium septicum bacteremia. Journal Of Pediatric Surgery Case Reports 2015, 3: 320-323. DOI: 10.1016/j.epsc.2015.05.014.Peer-Reviewed Original ResearchTemsirolimus therapyBowel perforationPediatric patientsLife-threatening side effectsSignificant disease stabilizationSmall bowel perforationCommon adverse effectsClostridium septicum infectionSmall bowel resectionHigh-grade gliomasBowel ischemiaDisease stabilizationBowel resectionSepticum infectionMetastatic rhabdomyosarcomaFrank necrosisSide effectsGastrointestinal pathogensTemsirolimusAdverse effectsPerforationPatientsRhabdomyosarcomaTherapyChildren